Pages

Thursday, June 29, 2017

IMPRIMIS PHARMACEUTICALS, INC. (NASDAQ:IMMY) Files An 8-K ...

www.4-traders.com › Equities › Nasdaq › Imprimis Pharmaceuticals Inc
6 hours ago - The Company operates through the business of developing drug therapies ... on developing and dispensing a portfolio of non-proprietary compounded drugs fo